Dr Reddy’s and Nestlé Health Science have strengthened their presence in India’s growing obesity nutrition care market with the launch of Celevida GLP+, a nutrition supplement designed for people using GLP-1 and GIP-based therapies for obesity...
JANANI Digital Health Platform has been launched by the Ministry of Health and Family Welfare. The platform aims to strengthen Maternal Care in India by creating a unified digital system for tracking care across pregnancy, childbirth, and...
New research on weight loss drugs suggests these medications may affect more than appetite and body weight. Scientists have found that newer GLP-1-based treatments could alter the brain’s reward system, potentially changing how people experience...
India-based Venus Remedies has secured marketing approval in Argentina for its antibiotic drug used to treat serious bacterial infections, marking another step in the company’s global expansion strategy. The approval allows the pharmaceutical...
The medical devices sector in India received a major push after the (YEIDA) signed a memorandum of understanding with (MEJ) to strengthen manufacturing, technology transfer, and investment in the industry.
India’s private healthcare crisis is raising serious concerns about the future of affordable treatment for millions of patients. Several leading private hospital chains are reconsidering their participation in government-backed health schemes...
The Zydus Biologics plant has received seven observations from the US Food and Drug Administration (USFDA) after a recent inspection at the company’s injectable manufacturing facility in Ahmedabad. The inspection was carried out betwe...
Star Health is expanding its affordable health insurance plans across tier-2 and tier-3 cities as the company looks to tap into rising healthcare awareness in smaller towns. The insurer’s latest move reflects the growing demand for low-cost heal...
Mounjaro has officially overtaken Merck’s Keytruda to become the world’s best-selling drug, marking a major shift in the global pharmaceutical market. The blockbuster diabetes treatment from Eli Lilly & Co. generated USD 8.7 billion in sales...
Aurobindo Pharma has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Telangana-based oral solid dosage manufacturing unit, marking the successful closure of a key regulatory inspect...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")